A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.
about
Differentiating bipolar disorder-not otherwise specified and severe mood dysregulationPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeThe neurobiological bases for development of pharmacological treatments of aggressive disordersEpidemiologic and clinical updates on impulse control disorders: a critical reviewThe pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-aCanadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorderRandomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.The Use of Antiepileptic Drugs (AEDs) for the Treatment of Pediatric Aggression and Mood Disorders.Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.Neuropsychiatry of aggression.Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behaviorTreatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation DisorderMedication strategies in childhood aggression: a review.The treatment of severe child aggression (TOSCA) study: Design challenges.Psychopharmacology of conduct disorder: current progress and future directions.Prepubertal bipolar disorder: available pharmacological treatment options.Deficits in emotion recognition in pediatric bipolar disorder: the mediating effects of irritabilityConcerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth EditionNeural Mechanisms of Cognitive-Behavioral Therapy for Aggression in Children and Adolescents: Design of a Randomized Controlled Trial Within the National Institute for Mental Health Research Domain Criteria Construct of Frustrative Non-Reward.Pharmacological treatment of pathologic aggression in children.Volitional disorders: a proposal for DSM-V.Recommendations for pharmacological management of inpatient aggression in children and adolescents.The neurobiology of oppositional defiant disorder and conduct disorder: altered functioning in three mental domains.Conduct disorders.Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.Evidence based administration of risperidone and paliperidone for the treating conduct disorder.Randomized controlled trials of psychopharmacological interventions of children and adolescents with conduct disorder: a descriptive analysis.Efficacy of antipsychotics for irritability and aggression in children: a meta-analysis.Pharmacotherapy of conduct disorder: Challenges, options and future directions.Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders.The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people.Wounding words: swearing and verbal aggression in an inpatient setting.Psychopharmacology column: the use of lithium carbonate with pediatric populations.Does the course of manic symptoms in pediatric bipolar disorder impact the course of conduct disorder? Findings from four prospective datasets
P2860
Q22252416-E1D88584-AD1E-43F8-BCEA-86780F81B4EBQ24648097-DA3D0737-4AF7-47BB-8A4A-CC0FD0B72E2AQ24651612-11B1FC5F-27F3-44B1-96EF-EA74972401C9Q24669677-16A00D12-0477-4F70-9CEB-ADBEACEFC389Q26849779-0D136352-7B42-49AB-8781-5D4B3C4E6C07Q28260681-1750C92B-EAFF-4DBA-BDF5-EE602525ABD3Q33411020-28B350C6-E55F-4024-93E4-496B1C35506DQ33664736-9E7DD505-0827-40D9-8F58-FDC50426922EQ34131298-CE35C8D9-14A4-4BB4-B874-7558E8C68EE6Q34152823-B5D1C194-B577-4494-8C7C-0A034151BCE4Q34155826-9C00F6D1-3F99-4829-93D7-BFE406CF4DE0Q34205524-1E1CF512-5662-450F-B5C3-9CA9EC6215D3Q34492314-5B008BE3-0AA0-4AA6-B4D2-9DA48E3200DCQ35190427-DFBEB1C8-C4CF-439E-BD1C-1886E5173ABBQ35595839-77DAB0B0-651C-4317-897D-5A737C980225Q35779213-9935459A-20A8-4BAF-902E-20E89AD4B101Q36150677-57B05DE6-5682-4EEC-B6C1-1821DBFCA4FEQ36442816-2CBD953C-2C8B-487E-8858-2E134FA001C6Q36635732-9B5836C2-B72A-4544-9C1D-CDB58F45499BQ36654452-FE29C3A3-3E46-48BB-9822-3BCC75EC16AAQ37127437-F2ACC923-A431-455A-9488-23D746986223Q37210109-61F7DD16-4C99-4B65-A895-46FE2A9881D6Q37726988-8AE86F71-97F7-4B19-8FBE-DDCBBC2C2404Q38026642-ACB40CA5-41EC-4A1D-AA4B-97A776A65B82Q38065966-FE17FB91-3905-4822-BDE5-D90F5E196293Q38084902-7100B4CF-4BF1-49EB-97D9-43BB49937F22Q38187654-C3DFA638-D58F-451B-90B7-D2B4BD6D7AC0Q38238114-8367394B-DC34-463A-B36A-30FE167AC347Q38605488-5AE1B5A4-DE13-4C6D-A5AF-0E135401EA41Q38839950-4A88AB5B-199E-4760-8DEE-A231A48B29C4Q44407169-906A9798-FAE8-4A79-829A-F4436B1CF25DQ44992894-9C0CA8CB-FBDE-47F7-8A8C-A624DED48915Q47586182-9554EFA4-CE4B-434D-A3CD-95D933344B8EQ48108717-2BDD85C1-6B8C-40E8-8404-EF3D08AABF21Q48586143-1A80A6D2-B876-4AA6-8B5C-E59D568FF2FEQ57399671-6A579904-6F7C-4388-8F89-78CB587B18B0
P2860
A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A double-blind placebo-control ...... escents with conduct disorder.
@en
A double-blind placebo-control ...... escents with conduct disorder.
@nl
type
label
A double-blind placebo-control ...... escents with conduct disorder.
@en
A double-blind placebo-control ...... escents with conduct disorder.
@nl
prefLabel
A double-blind placebo-control ...... escents with conduct disorder.
@en
A double-blind placebo-control ...... escents with conduct disorder.
@nl
P2093
P921
P1433
P1476
A double-blind placebo-control ...... escents with conduct disorder.
@en
P2093
P304
P356
10.1001/ARCHPSYC.57.7.649
P407
P577
2000-07-01T00:00:00Z